6951:TSEJEOL Ltd. Analysis
Data as of 2026-09-11 - not real-time
¥6,855.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
JEOL Ltd. trades at ¥6,855.00, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 11.7%. Momentum indicators put RSI at 41.8 (neutral) with MACD reading bullish. The recent range runs from support at ¥6,634.00 up to resistance at ¥7,727.00.
Multiples put this in undervalued territory: 15.9 times earnings against the sector's 33.3. Analyst price targets sit 27.5% above the current price. Revenue is contracting at 39.1%. The 1.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 72.3%, a beta of 0.95 and a maximum drawdown of 25.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
Multiples put this in undervalued territory: 15.9 times earnings against the sector's 33.3. Analyst price targets sit 27.5% above the current price. Revenue is contracting at 39.1%. The 1.83% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 72.3%, a beta of 0.95 and a maximum drawdown of 25.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Trading above the 200-day average of 6480.59
- MACD momentum is positive
- 30-day price change of -11.7%
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 15.9 versus sector average of 33.3
- Trading above the 200-day average of 6480.59
- Analyst targets imply +27.5% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 15.9 versus sector average of 33.3
- Analyst targets imply +27.5% versus the current price
- Revenue contracting at -39.1%
Key Metrics & Analysis
Financial Health
Revenue Growth-39.10%
P/E Ratio15.9
ROE11.30%
ROA5.11%
Debt/Equity10.14
P/B Ratio2.4
Industry P/E33.3
Technical Analysis
TrendNeutral
RSI41.8
Support¥6,634.00
Resistance¥7,727.00
MA 20¥7,091.00
MA 50¥7,690.84
MA 200¥6,480.59
MACDBullish
VolumeDecreasing
Fear & Greed Index93.11
Valuation
Target Price¥8,740.00
Upside/Downside27.50%
GradeUndervalued
TypeBlend
Dividend Yield1.83%
Risk Assessment
Beta0.95
Volatility72.27%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.